Hematopoietic stem cells and liver regeneration: Differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury

Blood Cells, Molecules, and Diseases

Volumn 53, Issue 3, 2014, Pages 124-132

  Tsolaki, Eleftheria ^a,b   Athanasiou, Evangelia ^a   Gounari, Eleni ^a,b   Zogas, Nikolaos ^a,b   Siotou, Eleni ^a   Yiangou, Minas ^b   Anagnostopoulos, Achilles ^a   Yannaki, Evangelia ^a  

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Chronic liver injury; Granulocyte Colony Stimulating Factor; Liver regeneration; Plerixafor; Stem cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYTOKERATIN 19; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLERIXAFOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; BIOLOGICAL MARKER; CARBON TETRACHLORIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HETEROCYCLIC COMPOUND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HOMING; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; HEMATOPOIETIC STEM CELL; HEPATITIS; LIVER BLOOD VESSEL; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; LIVER REGENERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL MOBILIZATION; ANIMAL; CYTOLOGY; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY, CHRONIC; FIBROSIS; IMMUNOHISTOCHEMISTRY; LIVER; METABOLISM; MORTALITY; PATHOLOGY; TIME;

MUS;

ANIMALS; BIOLOGICAL MARKERS; CARBON TETRACHLORIDE; DRUG-INDUCED LIVER INJURY, CHRONIC; FIBROSIS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER REGENERATION; MICE; TIME FACTORS;

EID: 84904746407     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2014.05.003     Document Type: Article

References (53)

1. Fausto N., Campbell J.S., Riehle K.J. Liver regeneration. Hepatology 2006, 43:S45-S53.
2. Michalopoulos G.K., DeFrances M.C. Liver regeneration. Science 1997, 276:60-66.
3. Bird T.G., Lorenzini S., Forbes S.J. Activation of stem cells in hepatic diseases. Cell Tissue Res. 2008, 331:283-300.
4. Dan Y.Y., Yeoh G.C. Liver stem cells: a scientific and clinical perspective. J. Gastroenterol. Hepatol. 2008, 23:687-698.
5. Lagasse E., Connors H., Al-Dhalimy M., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000, 6:1229-2934.
6. Petersen P.E., Bowen W.C., Patrene K.D., et al. Bone marrow as a potential source of hepatic oval cells. Science 1999, 284(5417):1168-1170.
7. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
8. Ferrari G., Cusella-De Angelis G., Coletta M., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998, 279:1528-1530.
9. Brazelton T.R., Rossi F.M., Keshet G.I., Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000, 290:1775-1779.
10. Ianus A., Holz G., Theise N., Hussain M. In vivo derivation of glucose competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J. Clin. Invest. 2003, 111:843-850.
11. Schwartz R.E., Reyes M., Koodie L., et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J. Clin. Invest. 2002, 109:1291-1302.
12. Alison M.R., Poulsom R., Jeffery R., et al. Hepatocytes from non-hepatic adult stem cells. Nature (London) 2000, 406:257.
13. Theise N.D., Nimmakayalu M., Gardner R., et al. Liver from bone marrow in humans. Hepatology 2000, 32:11-16.
14. Kallis Y.N., Alison M.R., Forbes S.J. Bone marrow stem cells and liver disease. Gut 2007, 56:716-724.
15. Wagers A.J., Sherwood R.I., Christensen J.L., WeisSMAn I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002, 297:2256-2259.
16. Thorgeirsson S.S., Grisham J.W. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006, 43:2-8.
17. Loffredo F.S., Steinhauser M.L., Gannon J., Lee R.T. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011, 8(4):389-398.
18. Tang X.L., Rokosh G., Sanganalmath S.K., et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010, 121(2):293-305.
19. Lemoli R.M., Catani L., Talarico S., et al. Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Stem Cells 2006, 24(12):2817-2825.
20. De Silvestro G., Vicarioto M., Donadel C., et al. Mobilization of periphery blood hematopoietic stem cells following liver resection surgery. Hepatogastroenterology 2004, 51(57):805-810.
21. To L.B., Haylock D.N., Simmons P.J., Juttner C.A. The biology and clinical uses of blood stem cells. Blood 1999, 89:2233-2258.
22. Mohty M., Ho A.D. In and out of the niche: perspectives in mobilization of hematopoietic stem cells. Exp. Hematol. 2011, 39(7):723-729.
23. Metcalf D. The molecular control of cell division, differentiation, commitment and maturation in haematopoietic cells. Nature 1989, 339:27-30.
24. Quintana-Bustamante O., Alvarez-Barrientos A., Kofman A.V., et al. Hematopoietic mobilization in mice increases the presence of bone marrow-derived hepatocytes via in vivo cell fusion. Hepatology 2006, 43:108-116.
25. Yannaki E., Athanasiou E., Xagorari A., et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp. Hematol. 2005, 33:108-119.
26. Bird T.G., Lu W.Y., Boulter L., et al. Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signalling. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(16):6542-6547.
27. Kishore R., Verma S.K., Mackie A.R., et al. Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts. PLoS One 2013, 8(4):e60161.
28. Piscaglia A.C., Shupe T.D., Oh S., Gasbarrini A., Petersen B.E. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology 2007, 133(2):619-631.
29. Broxmeyer H.E., Orschell C.M., Clapp D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 2005, 201:1307-1318.
30. Flomenberg N., Devine S.M., Dipersio J.F., et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 2005, 106:1867-1874.
31. Mark A.L., Sun Z., Warren D.S., et al. Stem cell mobilization is life saving in an animal model of acute liver failure. Ann. Surg. 2010, 252(4):591-596.
32. Brunt E.M., Janney C.G., Biscleglie A.M., et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999, 94:2467-2474.
33. Almeida-Porada G., Zanjani E.D., Porada C.D. Bone marrow stem cells and liver regeneration. Exp. Hematol. 2010, 38(7):574-580.
34. Motabi I.H., DiPersio J.F. Advances in stem cell mobilization. Blood Rev. 2012, 26(6):267-278.
35. Yannaki E., Anagnostopoulos A., Kapetanos D., et al. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp. Hematol. 2006, 34:1583-1587.
36. Gaia S., Smedile A., Omede P., et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J. Hepatol. 2006, 45:13-19.
37. + stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006, 24(7):1822-1830.
38. + cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J. Clin. Oncol. 2004, 22:1095-1102.
39. Mendt M., Cardier J.E. Stromal-derived factor-1 and its receptor, CXCR4, are constitutively expressed by mouse liver sinusoidal endothelial cells: implications for the regulation of hematopoietic cell migration to the liver during extramedullary hematopoiesis. Stem Cells Dev. 2012, 21(12):2142-2151.
40. Kawaguchi A., Orba Y., Kimura T., et al. Inhibition of the SDF-1α-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice. Blood 2009, 114:2961-2968.
41. Matsusue R., Kubo H., Hisamori S., et al. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann. Surg. Oncol. 2009, 16(9):2645-2653.
42. Wang Z., Xu J.P., Zheng Y.C., et al. Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats. Hepatobiliary Pancreat Dis. Int. 2011, 10(1):64-71.
43. Miyahara T., Schrum L., Rippe R., et al. Peroxisome proliferators activated receptors and hepatic stellate cell activation. J. Biol. Chem. 2000, 275:35715-35722.
44. Yang L., Chan C.C., Kwon O.S., et al. Regulation of peroxisome proliferator-activated receptor-γ in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G902-G911.
45. Hazra S., Xiong S., Wang J., et al. Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J. Biol. Chem. 2004, 279:11392-11401.
46. Galli A., Crabb D.W., Ceni E., et al. Antidiabetic thiazo-lidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002, 122:1924-1940.
47. Biscetti F., Gaetani E., Flex A., et al. Selective activation of peroxisome proliferator-activated receptor (PPAR) alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism. Diabetes 2008, 57(5):1394-1404.
48. Chintalgattu V., Harris G.S., Akula S.M., Katwa L.C. PPAR-γ agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. Cardiovasc. Res. 2007, 74:140-150.
49. Pola R., Gaetani E., Flex A., et al. Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator activated receptors. J. Mol. Cell. Cardiol. 2004, 36:363-370.
50. Corpechot C., Barbu V., Wendum D., et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 2002, 35(5):1010-1021.
51. Xu H., Shi B.M., Lu X.F., et al. Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats. World J. Gastroenterol. 2008, 14(15):2349-2357.
52. Stockmann C., Kerdiles Y., Nomaksteinsky M., et al. Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:4329-4334.
53. Yokomori H., Oda M., Yoshimura K., et al. Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells. Liver Int. 2003, 23:467-475.